Author: BusinessWire

EDP-938 achieved highly statistically significant (p<0.001) reductions in viral load and in resolution of clinical symptoms compared to placebo Conference…

DUBLIN–(BUSINESS WIRE)–The “Gout – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…

DUBLIN–(BUSINESS WIRE)–The “Familial Hypercholesterolemia – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report…

DUBLIN–(BUSINESS WIRE)–The “Cocaine Addiction – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report…

DUBLIN–(BUSINESS WIRE)–The “Retinal Vein Occlusion – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This…

DUBLIN–(BUSINESS WIRE)–The “Chikungunya Fever – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report…

DUBLIN–(BUSINESS WIRE)–The “Rett Syndrome – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report…

DUBLIN–(BUSINESS WIRE)–The “Whooping Cough – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report…

Up to 3.8 years of transfusion independence in Phase 1/2 Northstar (HGB-204) study in patients with TDT who do not…

In patients who were at least six months post-treatment with LentiGlobin for SCD, median level of abnormal sickle hemoglobin (HbS)…